50
Participants
Start Date
October 1, 2025
Primary Completion Date
October 1, 2026
Study Completion Date
October 1, 2026
Transarterial chemoembolization
Transarterial chemoembolization with FOLFOX plus/minus intravenous cetuximab/bevacizumab
Peking Union Medical College Hospital
OTHER
Junpeng Wang
OTHER